Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 220 people enrolled
- Started
- 20 Feb 2024
- Ended
- 5 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- HOME
- Record updated
- 7 April 2026
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Postpartum patients who have delivered a baby at the Hospital of University of Pennsylvania
- Ages 18 or older
- Self-identify as Black (listed on chart)
- Speak English
- Able to read
- Other characteristics defined by our risk prediction model (algorithm)
Who cannot take part
- Unable to provide informed consent
- Speaks a language other than English
Where in United States
- Hospital of the University of PennsylvaniaPhiladelphia, United States
About the trial
What the trial wants to find out
The goal of this educational clinical trial is to identify high-need women most at risk for poor outcomes following delivery, the problems they experience, and to create a system to improve quality of postpartum care for these high-need patients.
Read full original descriptionShow less
The main question[s] it aims to answer are:
1. How can the investigators help postpartum patients who have poor outcomes by decreasing the number of ED visits/readmissions for these patients within the first 30 days postpartum? 2. How can the investigators increase the ability of participants to "obtain needed services" and ability for patients to see their provider when they need to, in the 30-day post discharge period as one of the main pathways of unnecessary ED visits?
Participants will be put into the study group or control group. The study group will receive a pamphlet postpartum with helpful information as well as a patient navigator who the participants will be able to reach out to their first 30 days postpartum.
The 2 groups in the trial
- Patient Education Pamphlet and Partner SheetTreatment being tested
The study intervention consists of a patient education pamphlet and partner sheet (physically and virtually accessible) that will educate and prepare post-partum participants about health conditions (hypertension, diabetes, and depression), important health behaviors , physical and emotional postpartum symptoms, teach self-management skills, enhance social support, and connect post-partum participants with community resources. The education materials will provide simple actions that participants can utilize to address symptoms, realistic time frames for healing, danger signs to look out for and contact their physicians, and a list of resources for specific issues. The patient navigator will spend approximately 20 minutes with participants after enrollment, in the hospital. Following discharge, the patient navigator will contact each patient between 4 and 20 times, by phone and/or text with a research phone, to address questions and link participants to medical and community resources.
Treatment: HOME
- Standard Postpartum CareNo study treatment, for comparison
These patients will receive Standard postpartum care.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk: a Pilot Randomized Control Trial
- Record updated
- 7 April 2026